Long-term Outcomes of Tri-modality Therapy using a real-time tumor-tracking radiotherapy system for Patients with Muscle-invasive Bladder Cancer

被引：0
|
作者：
Miyata, Haruka [1 ]
Osawa, Takahiro [1 ]
Matsumoto, Ryuji [1 ]
Abe, Takashige [1 ]
Maruyama, Satoru [1 ]
Nishioka, Kentaro [2 ]
Shimizu, Shinichi [2 ]
Hashimoto, Takayuki [3 ]
Shirato, Hiroki [3 ]
Shinohara, Nobuo [1 ]
机构：
[1] Hokkaido Univ, Dept Renal & Genitourinary Surg, Sapporo, Hokkaido, Japan
[2] Hokkaido Univ, Dept Radiat Oncol, Sapporo, Hokkaido, Japan
[3] Hokkaido Univ, Dept Radiat Med, Sapporo, Hokkaido, Japan
来源：
INTERNATIONAL JOURNAL OF UROLOGY | 2018年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP-142
引用
收藏
页码：321 / 321
页数：1
相关论文
共 50 条
  • [1] The updated outcomes of bladder-preserving trimodal therapy using a real-time tumor-tracking radiotherapy system for patients with muscle-invasive bladder cancer
    Miyata, Haruka
    Osawa, Takahiro
    Abe, Takashige
    Kikuchi, Hiroshi
    Matsumoto, Ryuji
    Maruyama, Satoru
    Nishioka, Kentaro
    Shimizu, Shinichi
    Hashimoto, Takayuki
    Shirato, Hiroki
    Shinohara, Nobuo
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2020, 50 (05) : 609 - 616
  • [2] Long-term outcomes after bladder-preserving tri-modality therapy for patients with muscle-invasive bladder cancer
    Fabiano, Emmanuelle
    Durdux, Catherine
    Dufour, Bertrand
    Mejean, Arnaud
    Thiounn, Nicolas
    Chretien, Yves
    Bibault, Jean-Emmanuel
    Giraud, Philippe
    Kreps, Sarah
    Smulevici, Antoine
    Maraadji, Safia
    Housset, Martin
    [J]. ACTA ONCOLOGICA, 2021, 60 (06) : 794 - 802
  • [3] Bladder-preserving therapy using a real-time tumor-tracking radiotherapy system for muscle-invasive bladder cancer.
    Miyata, Haruka
    Osawa, Takahiro
    Frumido, Jun
    Kikuchi, Hiroshi
    Matsumoto, Ryuji
    Abe, Takashige
    Maruyama, Satoru
    Nishioka, Kentaro
    Shimizu, Shinichi
    Hashimoto, Takayuki
    Shirato, Hiroki
    Shinohara, Nobuo
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [4] Outcomes of Tri-Modality Bladder-Sparing Therapy for Muscle-Invasive Bladder Cancer
    Nguyen, E. K.
    Pond, G.
    Lukka, H.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E89 - E89
  • [5] Long-term results of bladder-preserving tri-modality treatment for muscle-invasive bladder cancer
    Nouhaud, F. -X.
    [J]. PROGRES EN UROLOGIE, 2017, 27 (01): : F16 - F17
  • [6] The Effect of Tri-Modality Therapy with Bladder Preservation for Selective Muscle-Invasive Bladder Cancer
    Zhang Zhiyu
    Zhou Qi
    Song Zhen
    Ouyang Jun
    Zhang Jianglei
    [J]. TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2021, 20
  • [7] Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital Experience
    Giacalone, Nicholas J.
    Shipley, William U.
    Clayman, Rebecca H.
    Niemierko, Andrzej
    Drumm, Michael
    Heney, Niall M.
    Michaelson, Marc D.
    Lee, Richard J.
    Saylor, Philip J.
    Wszolek, Matthew F.
    Feldman, Adam S.
    Dahl, Douglas M.
    Zietman, Anthony L.
    Efstathiou, Jason A.
    [J]. EUROPEAN UROLOGY, 2017, 71 (06) : 952 - 960
  • [8] Stereotactic Radiotherapy Boost as Part of Tri-Modality Treatment for Bladder Preservation in Patients with Muscle-Invasive Bladder Cancer
    Qin, S. B.
    Gao, X. S.
    Zhang, C. J.
    Li, H. Z.
    Yu, W.
    Hao, H.
    Yao, L.
    He, Z. S.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E205 - E206
  • [9] Long-term Outcomes After Bladder-Preserving Combined Modality Therapy for Patients With Muscle-Invasive Bladder Cancer
    Giacalone, N. J.
    Clayman, R. H.
    Efstathiou, J. A.
    Niemierko, A.
    Heney, N. M.
    Michaelson, M. D.
    McGovern, F. J.
    Kaufman, D. S.
    Zietman, A. L.
    Shipley, W. U.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : S22 - S23
  • [10] Pembrolizumab monotherapy following tri-modality treatment for selected patients with muscle-invasive bladder cancer
    Qin, S. B.
    Yu, W.
    He, Z. S.
    Gao, X. S.
    Hao, H.
    Bai, Y.
    Li, H. Z.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S1210 - S1210
12345